SOMD Stock UPDATES Studio One Media Inc. (SOMD) 0.4100 09/13/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Studio One Media Inc. (SOMD) 0.4100 $SOMD

Studio One Media and ON Semiconductor to Jointly Develop Audio Solutions That Deliver Unprecedented Performance for Consumer and Industrial Electronics
Business Wire - Tue Apr 01, 3:44PM CDT
Studio One Media, Inc. (OTCQB:SOMD) has entered into an agreement with ON Semiconductor (Nasdaq: ONNN) to develop integrated circuits (ICs) utilizing Studio One's award-winning AfterMaster(TM) audio technology and ON Semiconductor's DSP product development expertise.

Modern Mobility Aids Announces New Auditors and New President and Director
Marketwire - Wed Feb 26, 1:45PM CST
Nevada-based Modern Mobility Aids, Inc. (OTC Pink: MDRM) (the "Company" has recently appointed new auditors, Cutler & Co LLC of Denver Colorado as their auditors replacing their old auditors because of retirement and sale of the practice to Cutler. Cutler is working diligently with the company to bring all filings current asap. The Company is also pleased to announce the appointment of Mr. Preston Shea as both a Director and President of the company.

OTC Daily Alert Stock Watch - Studio One Media, Inc. (OTCQB: SOMD)
WorldStockWire - Fri Sep 06, 9:00PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

Studio One Media Reports Record Revenues and Reduced Losses for First Quarter of 2013
Marketwire - Thu May 16, 8:02AM CDT
Studio One Media, Inc., ("Company" (OTCBB: SOMD) (OTCQB: SOMD), a leading-edge media & technology company, today reported that its financial results for the quarter ended March 31, 2013, reflect both record revenues and substantial reductions in operating costs and operating losses.

Studio One Media Inks Deal for Coors Light National Mobile MyStudio Tour
Marketwire - Fri Feb 01, 8:00AM CST
Studio One Media, Inc. (OTCQC: SOMD) (OTCQB: SOMD), a leading edge entertainment & technology company, today announced that it has finalized a major sponsorship deal with one of the world's largest brewing companies to utilize Studio One's new state-of-the-art Mobile MyStudio(R) HD Recording Studio for a national social media tour this spring. The mobile MyStudio will be host to the "Coors Light Search For The Coldest" nationwide MC (rapper) search. The MyStudio social touring unit will canvass the streets of the US, helping to bring awareness to consumers about the program, as well as seeking out those who aspire to enter the competition... seeing if he/she has what it takes to be crowned "The Coldest." The competition's celebrity guest judges will consist of Ice Cube, Bun B, and DJ Drama. Starting April 1, complete contest details can be found by visiting www.searchforthecoldest.com.

Studio One Media Adds Public Company and Entertainment Veterans
Marketwire - Tue Jan 29, 8:20AM CST
Studio One Media, Inc. (OTCBB: SOMD) (OTCQB: SOMD), a leading edge entertainment and technology company, today announced that Mr. Stanton Ross has joined its Board of Directors and Mr. Dick Wingate has joined the Company as a senior consultant.

OTC Signal Daily Stock Watch - Studio One Media, Inc. (SOMD)
WorldStockWire - Mon Dec 17, 2:00AM CST
OTC Signal tracks stocks daily and is pleased to offer its stock alerts. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Signal at the following: http://www.otcsignal.com




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 431

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 175

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 229

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 162

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 310

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 308

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 218

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

Orion Corporation's Manager Transactions Highlight Executive Moves

Updated Category News Views 133

Understanding Orion Corporation's Executive Transactions Orion Corporation, a prominent player in the global pharmaceutical industry, has recently disclosed significant transactions involving its management, shedding light on financial movements that reflect company growth and strategy. Key Details on Managerial Transactions Recently, Orion Corporation reported under the...

Continue Reading
Congressman Questions SEC's 'Digital Asset Security' Definition

Updated Category News Views 150

Congressman Ritchie Torres Questions SEC's Use of Terminology Representative Ritchie Torres, a Democratic representative from New York, has recently shared his concerns about the phrase "digital asset security" as used by the U.S. Securities and Exchange Commission (SEC). He’s particularly interested in the legal basis and origins of this term. Congressional Dialogue...

Continue Reading
Investigating Claims for StubHub Investors: Your Options

Updated Category News Views 173

Investigation of Claims on Behalf of StubHub Investors Faruqi & Faruqi, LLP, a prominent name in national securities law, is currently looking into potential claims related to StubHub Holdings, Inc. (NYSE: STUB). This initiative aims to assist investors who might have faced losses due to the misleading statements made about the company's financial performance during its...

Continue Reading
Sarepta Therapeutics Faces Class Action Amid Safety Concerns

Updated Category News Views 256

Introduction to Sarepta Therapeutics Sarepta Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative therapies for rare diseases, particularly those associated with genetic factors. The company is well-known for its gene therapy treatments and aims to revolutionize treatment options for patients with Duchenne muscular dystrophy and similar...

Continue Reading